Whose drug is it anyway? [8]

Lancet

Volumn 358, Issue 9289, 2001, Pages 1275-

  Tramèr, Martin R ^a   Reynolds, D John M ^b   Goodman, Neville W ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DROPERIDOL; HALOPERIDOL; METOCLOPRAMIDE; OPIATE; SEROTONIN ANTAGONIST;

AMBULATORY SURGERY; ANESTHESIOLOGY; ANTIEMETIC ACTIVITY; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG USE; HUMAN; LETTER; MENTAL PATIENT; POSTOPERATIVE NAUSEA; POSTOPERATIVE PAIN; POSTOPERATIVE VOMITING; PRIORITY JOURNAL; QT INTERVAL; SURGICAL PATIENT; POSTOPERATIVE NAUSEA AND VOMITING;

ANTIEMETICS; DROPERIDOL; HUMANS; POSTOPERATIVE NAUSEA AND VOMITING;

EID: 0035856210     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06371-1     Document Type: Letter

References (5)

1. French survey of anesthesia in 1996
2. A rational approach to the control of postoperative nausea and vomiting: Evidence from systematic reviews, part I: Efficacy and harm of antiemetic interventions, and methodological issues
3. A postoperative analysis of the patient's view of anaesthesia in a Netherlands' teaching hospital
4. How much are patients willing to pay to avoid postoperative nausea and vomiting?
5. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting